日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

China sets more funds for HIV research

Updated: 2011-09-15 07:28

By Shan Juan (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

BANGKOK - China invested more than $18 million in HIV vaccine research and development in 2010, becoming the third largest contributor globally, after the United States and the European Union, according to a report endorsed by UNAIDS.

Internationally, HIV vaccine research and development (R&D) funding stood at $859 million last year, $9 million less than 2009, while China increased its spending by nearly $4 million over the same period, said the global report issued jointly by international organizations including AIDS Vaccine Advocacy Coalition (AVAC) and Intentional AIDS Vaccine Initiative.

"The long-term nature of vaccine research will require sustained investments globally and more developing countries like China are expected to shoulder more responsibilities," Kevin Fisher, the coalition's policy director said at the 2011 AIDS Vaccine Conference, which opened on Tuesday.

Unfortunately, overall global funding for HIV R&D has flattened out since 2000 and some early supporters, such as Canada and Sweden, have cut back, said the report. In the EU, a major contributor, funding has declined by 23 per cent since 2007.

In contrast, the Chinese government has pledged to further boost funding for HIV vaccine development by at least 20 percent in five years, according to Shao Yiming, director of the virology and immunology department of the National Center for AIDS/STD Control and Prevention.

Currently, China has four major HIV vaccine candidates under development on the mainland, all financed by the government.

"Compared with many developed countries like the US, which has dozens of HIV vaccine candidates under development, China needs more to have a better chance of success," Shao said.

His team is now waiting for approval from China's drug authorities to enter the second phase of the clinical trial for their HIV vaccine candidate, Tiantan.

Usually a vaccine has to undergo three phases of human trials before being licensed for use, experts said. The first two phases mainly test its safety and the third mainly its efficacy.

By May, 24 HIV vaccine candidates had entered the human trial stages across the world, including Tiantan, which is the only one from China to have reached that point.

Shao urged the Chinese government to regularly increase funding for vaccine development, particularly when some attention has been diverted to new prevention measures with proven efficacy.

"An effective and affordable vaccine is unanimously recognized as the ultimate weapon against HIV/AIDS worldwide," he said.

"The funding and human resources for vaccine R&D in China should be diversified and stakeholders like charities and industry should join in the effort."

Currently, all such studies on the mainland are funded and organized by the government, he said.

Half of the resources come from non-public sectors like pharmaceutical companies and philanthropic organizations, according to Shao.

As well, Kevin Fisher called on the Chinese government to be more transparent and to collaborate with international researchers in HIV vaccine development.

He said the Chinese authorities were usually reluctant to share relevant information, such as the amount of investment, with international stakeholders.

主站蜘蛛池模板: 男人的天堂久久 | 午夜院线 | 成人免费在线视频网站 | 亚洲欧美一区二区久久香蕉 | a级毛片免费高清视频 | 91精品国产免费久久久久久 | 91在线| 99免费观看视频 | 久久综合综合久久 | 闲人综合网 | aaaaaaa片毛片免费观看 | 久久视屏这里只有精品6国产 | 日本高清在线观看视频www | 欧美激情图片区 | 亚洲免费一级视频 | 欧美 亚洲 另类 激情 另类 | 亚洲精品无码成人A片在线虐 | 免费欧美黄色网址 | 日韩有码一区 | 成人午夜动漫在线观看 | 国产在线视频一区二区 | 波多野一区| 天天天天操 | 美女求操 | 亚洲国产成a人v在线 | 亚洲精品无码国产爽快A片百度 | 成人免费视频网站在线观看 | 亚洲一区二区视频在线观看 | 欧美变态口味重另类日韩毛片 | 91高清视频在线免费观看 | 久久精品二区 | 亚洲碰碰 | 国产精品福利短视在线播放频 | 一起射综合网 | 一本一道久久a久久精品蜜桃 | 亚洲午夜成激人情在线影院 | 免费观看一级特黄欧美大片 | 妇女毛片 | 亚洲精品一区二区三区福利 | 中文字幕在线免费看 | 激情 一区 |